Cisplatin and gemcitabine combined with herceptin in patients (pt) with her2 overexpressing, untreated, advanced, non-small-cell lung cancer (NSCLC): a phase II trial
- 1 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S154
- https://doi.org/10.1016/s0959-8049(01)81052-2
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: